| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZFP69 ZNF658B ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 FOXF2 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 RELA IRX1 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 TBX19 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 EP300 ZNF669 | 3.07e-21 | 1459 | 231 | 64 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZFP69 ZNF658B ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 FOXF2 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 RELA IRX1 ZNF879 ZFX ZNF563 ZNF711 ZNF419 TBX19 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 7.26e-20 | 1412 | 231 | 61 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZNF658B ZNF623 SNAI3 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 FOXF2 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 RELA IRX1 ZNF501 ZNF879 ZFX ZNF710 ZNF711 ZNF419 TBX19 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF350 ZNF853 ZNF583 EP300 | 5.34e-19 | 1244 | 231 | 56 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZNF658B ZNF623 SNAI3 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 FOXF2 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 RELA IRX1 ZNF501 ZNF879 ZFX ZNF710 ZNF711 ZNF419 TBX19 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF350 ZNF853 ZNF583 EP300 | 1.42e-18 | 1271 | 231 | 56 | GO:0000987 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.96e-18 | 114 | 231 | 20 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.67e-17 | 124 | 231 | 20 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.26e-16 | 137 | 231 | 20 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 ADGB USP17L6P USP17L22 USP17L15 USP17L8 | 8.37e-15 | 192 | 231 | 21 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | PCSK5 USP17L21 USP17L1 USP17L20 USP9X USP17L19 F11 USP17L18 METAP1 USP17L17 USP17L3 AGTPBP1 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 ADGB UNC5CL USP17L6P USP17L22 USP17L15 USP17L8 | 4.54e-08 | 654 | 231 | 26 | GO:0008233 |
| GeneOntologyMolecularFunction | L-leucine binding | 5.17e-05 | 7 | 231 | 3 | GO:0070728 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 1.33e-04 | 2 | 231 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 1.33e-04 | 2 | 231 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 1.33e-04 | 2 | 231 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 1.33e-04 | 2 | 231 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF143 ZNF658 ZNF225 ZNF699 ZNF658B KLF9 PLAG1 FOXF2 ZNF345 FEZF2 ZNF212 RELA ZFX TBX19 KLF10 ZNF197 ZNF721 | 2.96e-04 | 560 | 231 | 17 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF143 ZNF658 ZNF225 ZNF699 ZNF658B KLF9 PLAG1 FOXF2 ZNF345 FEZF2 ZNF212 RELA ZFX TBX19 KLF10 ZNF197 ZNF721 | 3.35e-04 | 566 | 231 | 17 | GO:0001216 |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.30e-03 | 5 | 231 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | ZNF219 ZNF205 MYNN ZNF699 SNAI3 FEZF2 RELA IRX1 ZBTB32 ZNF721 ZNF350 | 1.31e-03 | 320 | 231 | 11 | GO:0001227 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | ZNF219 ZNF205 MYNN ZNF699 SNAI3 FEZF2 RELA IRX1 ZBTB32 ZNF721 ZNF350 | 1.52e-03 | 326 | 231 | 11 | GO:0001217 |
| GeneOntologyMolecularFunction | amino acid binding | 1.57e-03 | 73 | 231 | 5 | GO:0016597 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.49e-17 | 125 | 235 | 20 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.62e-16 | 144 | 235 | 20 | GO:0070646 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L21 USP17L1 USP17L20 USP9X BSPRY PSMD10 USP17L19 USP17L18 FBXO25 USP17L17 USP17L3 AGTPBP1 FOXF2 USP17L13 UBR2 USP17L4 USP17L2 USP17L12 USP17L11 PARP2 USP17L24 USP17L5 RNF213 RELA USP17L10 GSK3B NEURL3 DCAF10 USP17L6P MTBP PRKCG USP17L22 USP17L15 USP17L8 | 6.51e-08 | 1074 | 235 | 34 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L21 USP17L1 USP17L20 USP9X BSPRY PSMD10 USP17L19 USP17L18 FBXO25 USP17L17 USP17L3 FOXF2 USP17L13 UBR2 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 RNF213 RELA USP17L10 GSK3B NEURL3 DCAF10 USP17L6P MTBP PRKCG USP17L22 USP17L15 USP17L8 | 1.59e-07 | 1009 | 235 | 32 | GO:0070647 |
| GeneOntologyBiologicalProcess | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 7.84e-05 | 8 | 235 | 3 | GO:0071947 | |
| GeneOntologyCellularComponent | septin complex | 3.11e-07 | 14 | 234 | 5 | GO:0031105 | |
| GeneOntologyCellularComponent | septin ring | 3.11e-07 | 14 | 234 | 5 | GO:0005940 | |
| GeneOntologyCellularComponent | septin cytoskeleton | 6.65e-07 | 16 | 234 | 5 | GO:0032156 | |
| GeneOntologyCellularComponent | sperm annulus | 1.11e-04 | 9 | 234 | 3 | GO:0097227 | |
| GeneOntologyCellularComponent | cell division site | 2.78e-04 | 80 | 234 | 6 | GO:0032153 | |
| GeneOntologyCellularComponent | phagophore | 3.72e-04 | 3 | 234 | 2 | GO:0061908 | |
| Domain | - | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZNF235 ZFP69 ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 6.51e-34 | 679 | 227 | 59 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZNF235 ZFP69 ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 2.18e-33 | 694 | 227 | 59 | IPR013087 |
| Domain | zf-C2H2 | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZNF235 ZFP69 ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 ZNF264 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 1.98e-32 | 693 | 227 | 58 | PF00096 |
| Domain | Znf_C2H2-like | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF318 ZNF225 ZNF699 ZNF235 ZFP69 ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 KAT7 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 5.10e-32 | 796 | 227 | 61 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF318 ZNF225 ZNF699 ZNF235 ZFP69 ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 KAT7 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 1.18e-31 | 808 | 227 | 61 | SM00355 |
| Domain | Znf_C2H2 | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZNF235 ZFP69 ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 KAT7 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 8.35e-31 | 805 | 227 | 60 | IPR007087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZNF235 ZFP69 ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 9.14e-31 | 775 | 227 | 59 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF225 ZNF699 ZNF235 ZFP69 ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 1.05e-30 | 777 | 227 | 59 | PS00028 |
| Domain | KRAB | ZNF765 ZNF658 ZNF337 ZNF460 ZNF205 ZNF571 ZNF225 ZNF699 ZNF235 ZFP69 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 ZNF283 ZNF264 ZNF578 ZNF211 ZNF607 ZNF212 ZNF316 ZNF805 ZNF879 ZNF563 ZNF419 ZNF182 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF350 ZNF583 ZNF669 | 8.30e-24 | 358 | 227 | 37 | PS50805 |
| Domain | KRAB | ZNF765 ZNF658 ZNF337 ZNF460 ZNF205 ZNF571 ZNF225 ZNF699 ZNF235 ZFP69 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 ZNF283 ZNF264 ZNF578 ZNF211 ZNF607 ZNF212 ZNF316 ZNF805 ZNF879 ZNF563 ZNF419 ZNF182 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF350 ZNF583 ZNF669 | 2.66e-23 | 370 | 227 | 37 | IPR001909 |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 4.85e-23 | 16 | 227 | 13 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 4.85e-23 | 16 | 227 | 13 | IPR006861 |
| Domain | KRAB | ZNF765 ZNF658 ZNF337 ZNF460 ZNF205 ZNF571 ZNF225 ZNF699 ZNF235 ZFP69 ZNF785 ZNF440 ZNF77 ZNF490 ZNF283 ZNF264 ZNF578 ZNF211 ZNF607 ZNF212 ZNF316 ZNF805 ZNF879 ZNF563 ZNF419 ZNF182 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF350 ZNF583 ZNF669 | 9.08e-23 | 358 | 227 | 36 | PF01352 |
| Domain | KRAB | ZNF765 ZNF658 ZNF337 ZNF460 ZNF205 ZNF571 ZNF225 ZNF699 ZNF235 ZFP69 ZNF785 ZNF440 ZNF77 ZNF490 ZNF283 ZNF264 ZNF578 ZNF211 ZNF607 ZNF212 ZNF316 ZNF805 ZNF879 ZNF563 ZNF419 ZNF182 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF350 ZNF583 ZNF669 | 2.55e-22 | 369 | 227 | 36 | SM00349 |
| Domain | zf-C2H2_6 | ZNF765 ZNF658 ZNF571 MYNN ZNF225 ZNF699 ZNF440 ZNF77 ZNF490 ZNF283 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZNF710 ZNF419 ZNF182 ZSCAN10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF721 ZNF80 ZNF669 | 1.59e-21 | 314 | 227 | 33 | PF13912 |
| Domain | UCH | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 2.98e-19 | 71 | 227 | 18 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 2.98e-19 | 71 | 227 | 18 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 3.94e-19 | 72 | 227 | 18 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 3.94e-19 | 72 | 227 | 18 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 3.94e-19 | 72 | 227 | 18 | IPR001394 |
| Domain | USP_CS | USP17L21 USP17L1 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 2.24e-18 | 66 | 227 | 17 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L20 USP9X USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L8 | 6.71e-18 | 70 | 227 | 17 | PS00972 |
| Domain | G_SEPTIN_dom | 3.02e-07 | 13 | 227 | 5 | IPR030379 | |
| Domain | Septin | 3.02e-07 | 13 | 227 | 5 | PF00735 | |
| Domain | G_SEPTIN | 3.02e-07 | 13 | 227 | 5 | PS51719 | |
| Domain | Septin | 4.65e-07 | 14 | 227 | 5 | IPR016491 | |
| Domain | SCAN_BOX | 6.34e-06 | 58 | 227 | 7 | PS50804 | |
| Domain | SCAN | 5.90e-05 | 56 | 227 | 6 | SM00431 | |
| Domain | SCAN | 7.21e-05 | 58 | 227 | 6 | PF02023 | |
| Domain | SCAN_dom | 7.21e-05 | 58 | 227 | 6 | IPR003309 | |
| Domain | Retrov_capsid_C | 7.94e-05 | 59 | 227 | 6 | IPR008916 | |
| Domain | ELFV_dehydrog_N | 1.47e-04 | 2 | 227 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 1.47e-04 | 2 | 227 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 1.47e-04 | 2 | 227 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 1.47e-04 | 2 | 227 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 1.47e-04 | 2 | 227 | 2 | PF00208 | |
| Domain | NAD_bind_Glu_DH | 1.47e-04 | 2 | 227 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 1.47e-04 | 2 | 227 | 2 | PS00074 | |
| Domain | ATG2 | 1.47e-04 | 2 | 227 | 2 | IPR026849 | |
| Domain | ELFV_dehydrog | 1.47e-04 | 2 | 227 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 1.47e-04 | 2 | 227 | 2 | IPR033524 | |
| Domain | ATG2_CAD | 1.47e-04 | 2 | 227 | 2 | PF13329 | |
| Domain | ATG2_CAD_motif | 1.47e-04 | 2 | 227 | 2 | IPR026885 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 4.38e-04 | 3 | 227 | 2 | IPR006794 | |
| Domain | Zfx_Zfy_act | 4.38e-04 | 3 | 227 | 2 | PF04704 | |
| Domain | AbLIM_anchor | 8.68e-04 | 4 | 227 | 2 | PF16182 | |
| Domain | - | 8.68e-04 | 4 | 227 | 2 | 1.10.800.10 | |
| Domain | ArAA_hydroxylase_Fe/CU_BS | 8.68e-04 | 4 | 227 | 2 | IPR018301 | |
| Domain | BH4_AAA_HYDROXYL_2 | 8.68e-04 | 4 | 227 | 2 | PS51410 | |
| Domain | ArAA_hydroxylase | 8.68e-04 | 4 | 227 | 2 | IPR001273 | |
| Domain | Biopterin_H | 8.68e-04 | 4 | 227 | 2 | PF00351 | |
| Domain | AbLIM_anchor | 8.68e-04 | 4 | 227 | 2 | IPR032402 | |
| Domain | Tyrosine_3-monooxygenase-like | 8.68e-04 | 4 | 227 | 2 | IPR019773 | |
| Domain | Aromatic-AA_hydroxylase_C | 8.68e-04 | 4 | 227 | 2 | IPR019774 | |
| Domain | BH4_AAA_HYDROXYL_1 | 8.68e-04 | 4 | 227 | 2 | PS00367 | |
| Domain | Autophagy-rel_C | 1.44e-03 | 5 | 227 | 2 | IPR015412 | |
| Domain | ATG_C | 1.44e-03 | 5 | 227 | 2 | PF09333 | |
| Domain | Adcy_conserved_dom | 2.14e-03 | 6 | 227 | 2 | IPR009398 | |
| Domain | DUF1053 | 2.14e-03 | 6 | 227 | 2 | PF06327 | |
| Domain | Cu_oxidase_Cu_BS | 2.14e-03 | 6 | 227 | 2 | IPR002355 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 LYPLA1 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.63e-25 | 45 | 176 | 19 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L1 USP17L20 USP9X PSMD10 PSMD12 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.55e-14 | 191 | 176 | 21 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L1 USP17L20 USP9X PSMD10 PSMD12 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 USP17L8 | 4.64e-13 | 221 | 176 | 21 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L1 USP17L20 USP9X PSMD10 PSMD12 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 EP300 USP17L15 USP17L8 | 1.54e-12 | 262 | 176 | 22 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L1 USP17L20 USP9X PSMD10 PSMD12 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 EP300 USP17L15 USP17L8 | 2.13e-11 | 299 | 176 | 22 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L1 USP17L20 PSMD10 PSMD12 USP17L19 USP17L18 USP17L17 LYPLA1 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.66e-10 | 318 | 176 | 21 | MM15278 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF143 ZNF658 ZNF337 ZNF460 USP9X ZNF205 ZNF571 PSMD10 PSMD12 KCTD1 ZNF225 ZNF699 ZNF235 ZFP69 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 INTS14 ZNF264 ZNF211 ZNF607 ZNF212 APAF1 GPAM RELA GSK3B ZNF710 ZNF563 ZNF711 ZNF419 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF74 ZNF721 ZNF350 HDAC10 ZNF583 EP300 ZNF669 | 4.14e-09 | 1387 | 176 | 44 | M734 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P IL1R1 USP17L22 USP17L15 USP17L8 | 5.15e-37 | 25 | 236 | 19 | 21115691 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.28e-37 | 21 | 236 | 18 | 8622927 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.28e-37 | 21 | 236 | 18 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.28e-37 | 21 | 236 | 18 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.28e-37 | 21 | 236 | 18 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.28e-37 | 21 | 236 | 18 | 12447969 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.28e-37 | 21 | 236 | 18 | 18980247 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 ZSCAN4 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.90e-36 | 26 | 236 | 19 | 35816173 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.43e-36 | 22 | 236 | 18 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.24e-35 | 24 | 236 | 18 | 8995226 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.27e-33 | 33 | 236 | 19 | 20228807 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 19188362 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 11941478 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 17109758 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 20368735 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 10936051 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.12e-33 | 34 | 236 | 19 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.11e-32 | 35 | 236 | 19 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.11e-32 | 35 | 236 | 19 | 21239494 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.56e-32 | 29 | 236 | 18 | 32527007 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.34e-32 | 36 | 236 | 19 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.79e-32 | 37 | 236 | 19 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.17e-27 | 50 | 236 | 18 | 31806660 |
| Pubmed | ZNF460 ZNF699 ZNF235 ZNF785 ZNF440 ZNF77 ZNF490 ZNF264 ZNF211 ZNF607 ZNF316 ZNF805 ZNF563 ZNF419 ZNF182 ZNF197 ZNF432 ZNF74 ZNF721 ZNF583 ZNF669 | 6.84e-20 | 181 | 236 | 21 | 37372979 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 7.15e-14 | 10 | 236 | 7 | 24207026 | |
| Pubmed | 4.66e-13 | 12 | 236 | 7 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 2.00e-12 | 14 | 236 | 7 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 2.85e-11 | 19 | 236 | 7 | 28067227 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 ZNF235 OR6X1 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 MYOM3 USP17L5 USP17L10 ZNF711 ZNF182 USP17L6P DGKI USP17L22 USP17L15 USP17L8 | 4.83e-11 | 674 | 236 | 24 | 37196079 | |
| Pubmed | ZNF219 ZNF143 ZNF205 MYNN ZNF318 ZNF235 ZNF623 ZYX KLF9 PLAG1 ZNF212 RELA ZNF710 ZNF419 TBX19 KAT7 ABLIM1 KLF10 LPP HMGXB3 ZNF721 ABLIM2 | 4.15e-08 | 808 | 236 | 22 | 20412781 | |
| Pubmed | 5.67e-08 | 16 | 236 | 5 | 22575789 | ||
| Pubmed | Androglobin, a chimeric mammalian globin, is required for male fertility. | 1.48e-07 | 19 | 236 | 5 | 35700329 | |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 1.23e-06 | 4 | 236 | 3 | 22984479 | |
| Pubmed | p28(GANK) associates with p300 to attenuate the acetylation of RelA. | 1.23e-06 | 4 | 236 | 3 | 25400040 | |
| Pubmed | 1.38e-06 | 81 | 236 | 7 | 12838346 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 SPIRE2 ATG2A FAT1 SLC52A2 FRAS1 MTHFD1L L1CAM ZNF316 MYOM3 POLRMT PAPLN ATP13A2 C6orf132 MYOF KLF10 ZNF500 NPRL3 HMGXB3 TNFAIP2 BCAM EP300 SOWAHB | 2.20e-06 | 1105 | 236 | 23 | 35748872 |
| Pubmed | HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. | 1.06e-05 | 7 | 236 | 3 | 9560267 | |
| Pubmed | 1.13e-05 | 21 | 236 | 4 | 7865130 | ||
| Pubmed | Septin 14 is involved in cortical neuronal migration via interaction with Septin 4. | 1.68e-05 | 8 | 236 | 3 | 20181826 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L12 USP17L11 | 1.78e-05 | 119 | 236 | 7 | 28625976 |
| Pubmed | 2.51e-05 | 9 | 236 | 3 | 2293612 | ||
| Pubmed | Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission. | 2.51e-05 | 9 | 236 | 3 | 18809578 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | USP9X ATG2A ZYX SEPTIN6 SEPTIN8 AGTPBP1 RELA UPF1 XRCC3 GSK3B BBS10 KAT7 ABLIM1 STRAP CCNB2 GPN2 LPP DBR1 SEPTIN10 MTMR9 | 3.12e-05 | 1038 | 236 | 20 | 26673895 |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 3.42e-05 | 180 | 236 | 8 | 30110629 | |
| Pubmed | Interplay between protein acetylation and ubiquitination controls MCL1 protein stability. | 3.57e-05 | 10 | 236 | 3 | 34758305 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 2872999 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 34173171 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 28621566 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 28800131 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 32209671 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 18201972 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 32078638 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 23595828 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 34260947 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 22219374 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 31009605 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 21621574 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 28911206 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 31383768 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 22875990 | ||
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 4.59e-05 | 2 | 236 | 2 | 15578726 | |
| Pubmed | Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes. | 4.59e-05 | 2 | 236 | 2 | 15044002 | |
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 4.59e-05 | 2 | 236 | 2 | 22138648 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 34220417 | ||
| Pubmed | Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. | 4.59e-05 | 2 | 236 | 2 | 26241911 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 10978534 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 21446915 | ||
| Pubmed | NFкB is a critical transcriptional regulator of atypical cadherin FAT1 in glioma. | 4.59e-05 | 2 | 236 | 2 | 31992226 | |
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 4.59e-05 | 2 | 236 | 2 | 33526815 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 17068292 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 38060673 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 31162142 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 23975427 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 24593767 | ||
| Pubmed | Potentiation of neuronal activity by tonic GluD1 current in brain slices. | 4.59e-05 | 2 | 236 | 2 | 37154294 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 14622131 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 22924626 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 20431059 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 29790931 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 11032875 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 29943084 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 31898404 | ||
| Pubmed | Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux. | 4.59e-05 | 2 | 236 | 2 | 15378063 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 27422263 | ||
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 4.59e-05 | 2 | 236 | 2 | 36449053 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 15750346 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 1711373 | ||
| Pubmed | Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate. | 4.59e-05 | 2 | 236 | 2 | 20529287 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 25124006 | ||
| Pubmed | Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase. | 4.59e-05 | 2 | 236 | 2 | 23673664 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 23609114 | ||
| Pubmed | Adenylyl cyclase type 5 protein expression during cardiac development and stress. | 4.59e-05 | 2 | 236 | 2 | 19734365 | |
| Pubmed | Lack of evidence for direct ligand-gated ion channel activity of GluD receptors. | 4.59e-05 | 2 | 236 | 2 | 39052831 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 24442550 | ||
| Interaction | TRIM28 interactions | ZNF765 ZNF658 ZNF460 PSMD10 PSMD12 ZNF699 ZNF235 ZNF785 ZNF440 ZNF77 ZNF490 RECQL5 LYPLA1 ZNF264 PAK1IP1 ZNF211 ZNF607 MTHFD1L PARP2 APAF1 ZNF316 ZNF805 POLRMT UPF1 GSK3B ZNF563 ZNF419 ZNF182 STRAP PRIM2 ZNF197 ZNF256 ZNF432 ZNF816 MRPS9 ZNF74 ZNF721 ZNF350 HDAC10 ZNF583 EP300 EPB41L2 ZNF669 | 5.14e-09 | 1474 | 225 | 43 | int:TRIM28 |
| Interaction | FBLN5 interactions | ZNF765 ZNF460 ZNF235 ZNF440 ZNF77 RECQL5 FOXF2 POLRMT ZNF74 ZNF669 | 1.23e-05 | 159 | 225 | 10 | int:FBLN5 |
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P ABLIM2 USP17L22 USP17L15 | 1.19e-19 | 79 | 236 | 15 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P ZNF721 ABLIM2 USP17L22 USP17L15 | 5.34e-14 | 222 | 236 | 16 | chr4p16 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF765 QPCTL ZNF460 ZNF571 ZNF225 ZNF235 ZNF283 ZNF264 ZNF578 ZNF345 LILRB3 ZNF211 ZNF607 ZSCAN4 ZNF805 LILRA6 ZNF419 ZBTB32 KIR3DX1 ZNF540 ZNF256 ZNF432 ZNF816 PRKCG ZNF350 BCAM BRSK1 ZNF583 | 2.91e-11 | 1192 | 236 | 28 | chr19q13 |
| Cytoband | 19q13.4 | 1.84e-07 | 79 | 236 | 7 | 19q13.4 | |
| Cytoband | 19q13.43 | 9.02e-05 | 87 | 236 | 5 | 19q13.43 | |
| Cytoband | 3q13.3 | 1.57e-04 | 4 | 236 | 2 | 3q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 2.25e-04 | 234 | 236 | 7 | chr8p23 | |
| Cytoband | 19q13.41 | 7.21e-04 | 78 | 236 | 4 | 19q13.41 | |
| Cytoband | 4q21.1 | 9.16e-04 | 37 | 236 | 3 | 4q21.1 | |
| Cytoband | 8p23.1 | 1.25e-03 | 154 | 236 | 5 | 8p23.1 | |
| Cytoband | 16p13.3 | 1.73e-03 | 244 | 236 | 6 | 16p13.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF765 ZNF219 ZNF143 ZNF658 ZNF165 ZNF337 ZNF460 MAZ ZNF205 ZNF571 MYNN ZNF318 ZNF225 ZNF699 ZNF235 ZFP69 ZNF623 SNAI3 ZNF785 ZNF440 ZNF77 ZNF490 ZSCAN32 KLF9 ZNF283 PLAG1 ZNF264 ZNF578 ZNF345 ZNF211 ZNF607 FEZF2 ZSCAN4 ZNF212 ZNF316 ZNF805 ZNF501 ZNF879 ZFX ZNF710 ZNF563 ZNF711 ZNF419 ZNF182 ZBTB32 ZSCAN10 KLF10 ZNF540 ZNF197 ZNF256 ZNF500 ZNF432 ZNF816 ZNF74 ZNF721 ZNF80 ZNF350 ZNF853 ZNF583 ZNF669 | 4.92e-41 | 718 | 169 | 60 | 28 |
| GeneFamily | Septins | 8.15e-08 | 13 | 169 | 5 | 732 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 ZSCAN4 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.51e-21 | 86 | 232 | 19 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 7.76e-18 | 112 | 232 | 18 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 FOXF2 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.17e-16 | 160 | 232 | 19 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L1 USP17L20 USP17L19 ZNF699 USP17L18 USP17L17 GLUD1 GLUD2 USP17L3 C1QTNF1 AGTPBP1 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 APAF1 POLRMT USP17L5 USP17L10 ATP13A2 C6orf132 USP17L6P USP17L22 USP17L15 USP17L8 | 2.84e-11 | 647 | 232 | 27 | MM981 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L21 ZNF219 USP17L1 USP17L20 USP17L19 ZNF699 USP17L18 USP17L17 GLUD1 GLUD2 USP17L3 C1QTNF1 PAK1IP1 AGTPBP1 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 APAF1 POLRMT USP17L5 USP17L10 ATP13A2 C6orf132 STRAP USP17L6P EIF3B DBR1 USP17L22 USP17L15 USP17L8 | 4.47e-08 | 1226 | 232 | 32 | MM979 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L21 USP17L1 USP17L20 BSPRY ZNF205 MYNN USP17L19 SNAI3 SEPTIN6 USP17L18 METAP1 USP17L17 USP17L3 CCNI TBCE USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 APAF1 USP17L5 USP17L10 USP17L6P DBR1 USP17L22 USP17L15 EPB41L2 USP17L8 | 9.63e-08 | 1072 | 232 | 29 | MM1031 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L21 USP17L1 USP17L20 PSMD10 PSMD12 USP17L19 USP17L18 METAP1 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 GSK3B TTC7A HSD3B7 KLF10 UNC5CL USP17L6P MRPS9 SEPTIN11 USP17L22 USP17L15 DKK3 MTMR9 USP17L8 | 2.98e-07 | 1198 | 232 | 30 | MM1062 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_31_PRECICTIVE_ICB_RESISTANCE | ZNF699 FZD9 AMHR2 ZNF316 PAPLN ZNF879 TMEM88B ZNF711 ZSCAN10 DGKI ZNF853 | 1.94e-06 | 201 | 232 | 11 | MM17086 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ARHGEF17 ADCY5 SEPTIN8 FAT1 C1QTNF1 MYO1B MYOF SEPTIN11 SNTG2 DKK3 EPB41L2 | 7.80e-09 | 200 | 229 | 11 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ARHGEF17 ADCY5 FAT1 C1QTNF1 FOXF2 PAPLN MYOF SEPTIN11 SNTG2 DKK3 | 4.23e-08 | 184 | 229 | 10 | 102b6f621a5b551e622f97b12d787c080b052a72 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ARHGEF17 ADCY5 SEPTIN8 FAT1 C1QTNF1 MYO1B MYOF SEPTIN11 SNTG2 DKK3 | 9.26e-08 | 200 | 229 | 10 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ARHGEF17 ADCY5 SEPTIN8 FAT1 C1QTNF1 MYO1B MYOF SEPTIN11 SNTG2 DKK3 | 9.26e-08 | 200 | 229 | 10 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.26e-08 | 200 | 229 | 10 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | ARHGEF17 ADCY5 SEPTIN8 FAT1 C1QTNF1 MYO1B SEPTIN11 SNTG2 DKK3 EPB41L2 | 9.26e-08 | 200 | 229 | 10 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.95e-07 | 184 | 229 | 9 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ARHGEF17 ADCY5 SEPTIN8 FAT1 MYO1B SEPTIN11 SNTG2 DKK3 EPB41L2 | 9.93e-07 | 200 | 229 | 9 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 9.93e-07 | 200 | 229 | 9 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.93e-07 | 200 | 229 | 9 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 117 | 229 | 7 | 240cd636d1f5d3f270825ace02126fae993f5802 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-06 | 169 | 229 | 8 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-06 | 184 | 229 | 8 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.37e-06 | 185 | 229 | 8 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.79e-06 | 191 | 229 | 8 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-06 | 199 | 229 | 8 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.50e-06 | 200 | 229 | 8 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.50e-06 | 200 | 229 | 8 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 9.50e-06 | 200 | 229 | 8 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 9.50e-06 | 200 | 229 | 8 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.50e-06 | 200 | 229 | 8 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 9.50e-06 | 200 | 229 | 8 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 156 | 229 | 7 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 158 | 229 | 7 | d72d6527dc50207ddbada262460d3c4bac249a19 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.87e-05 | 159 | 229 | 7 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-05 | 169 | 229 | 7 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.87e-05 | 170 | 229 | 7 | adf73bdc049d508f8873c22539db2ca92052a97b | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 2.98e-05 | 171 | 229 | 7 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.10e-05 | 172 | 229 | 7 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-05 | 173 | 229 | 7 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-05 | 176 | 229 | 7 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.85e-05 | 178 | 229 | 7 | 86f1741636ed3e85bb4a65f84949b718fc38c290 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.75e-05 | 184 | 229 | 7 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.75e-05 | 184 | 229 | 7 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.75e-05 | 184 | 229 | 7 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-05 | 185 | 229 | 7 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 4.92e-05 | 185 | 229 | 7 | a62ebaff92f2ed27b27b32c27c89cfbe2cb35116 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.09e-05 | 186 | 229 | 7 | 827f2f2ddde315d1e5970dd56f906c555ec699af | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-05 | 189 | 229 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.74e-05 | 130 | 229 | 6 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 190 | 229 | 7 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.82e-05 | 190 | 229 | 7 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 190 | 229 | 7 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.82e-05 | 190 | 229 | 7 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.64e-05 | 194 | 229 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 6.64e-05 | 194 | 229 | 7 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|RA / Chamber and Cluster_Paper | 6.79e-05 | 134 | 229 | 6 | 60ee3accc54108e5b9a0018f6aa8488dc39d5ade | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.79e-05 | 134 | 229 | 6 | 0e3f37ef041b751ed45060b5ce39385a2731370b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.78e-05 | 199 | 229 | 7 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | Transverse-T_cell-Tfh|T_cell / Region, Cell class and subclass | 7.78e-05 | 199 | 229 | 7 | 33ffea12b8228e0b5bd8942531c3b21d24224725 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.78e-05 | 199 | 229 | 7 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.00e-05 | 138 | 229 | 6 | 5a713f24f633de463ef47ca37fbb2bb60c7fdb77 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 8.03e-05 | 200 | 229 | 7 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.03e-05 | 200 | 229 | 7 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 200 | 229 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 200 | 229 | 7 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.03e-05 | 200 | 229 | 7 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 200 | 229 | 7 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 8.32e-05 | 139 | 229 | 6 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 146 | 229 | 6 | 1bf67a9416f52198931b912a31be4bab09fefd19 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 148 | 229 | 6 | 10dcbdb47cac908648d9d652c8095b536db19b8a | |
| Drug | vinylene | ZNF219 ZNF460 MAZ ZNF235 FAT1 PLAG1 ZNF264 DPH1 FEZF2 ZFX ZBTB32 KLF10 ZNF197 EP300 | 1.26e-07 | 245 | 220 | 14 | CID000006326 |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; HL60; HG-U133A | ZNF219 PNPLA4 MAZ ATG2A CYRIA TBCE DPH1 APAF1 RELA LPP NPRL3 | 4.00e-06 | 199 | 220 | 11 | 1991_UP |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; PC3; HT_HG-U133A | ZNF337 ZNF318 ZSCAN32 ZNF710 ZNF419 P2RX5 ZNF197 TNFAIP2 BCAM ZMYM3 SOS2 | 4.20e-06 | 200 | 220 | 11 | 6303_DN |
| Drug | choline sulfate | 8.77e-06 | 5 | 220 | 3 | CID000000485 | |
| Drug | 2-methyl-1,2,3,4-tetrahydroisoquinoline | 1.74e-05 | 6 | 220 | 3 | CID000015362 | |
| Drug | SC 19220; Up 200; 10uM; PC3; HT_HG-U133A | 2.03e-05 | 194 | 220 | 10 | 7065_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; HL60; HG-U133A | 2.52e-05 | 199 | 220 | 10 | 1386_UP | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; HL60; HG-U133A | ARHGAP32 MAZ FCHO1 SEPTIN6 PAK1IP1 TBCE RELA KBTBD4 LPP IL1R1 | 2.52e-05 | 199 | 220 | 10 | 2012_UP |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A | ARHGAP32 ZNF337 RELA ZNF419 RBM12 KBTBD4 TNFAIP2 BCAM ZMYM3 SOS2 | 2.52e-05 | 199 | 220 | 10 | 7148_DN |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; HL60; HT_HG-U133A | CYRIA IL1RAPL2 RECQL5 ZNF345 APAF1 MYO1B ZNF710 NPRL3 ZNF350 TNFAIP2 | 2.52e-05 | 199 | 220 | 10 | 3073_DN |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.25e-29 | 46 | 225 | 19 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.84e-25 | 69 | 225 | 19 | DOID:1682 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRPHTDAVYHACFSE | 611 | O14727 | |
| LHVTRTGAHYILFPC | 266 | Q9H0X4 | |
| VHFFRPKCLRTAVYH | 1401 | Q09472 | |
| YFAQSHKPPFHGRVC | 936 | Q9P2K9 | |
| HGEAPRISVSFYHVK | 581 | P55884 | |
| YFHPTTTRLIKHPCE | 46 | Q86XM0 | |
| VLEAGDKHYHPSCAR | 296 | O14639 | |
| LFNAYSPVGHSIHIC | 751 | Q8N7X0 | |
| YCVSGLPEARADHAH | 431 | O43306 | |
| YEAVHRHPYPCSKAL | 151 | Q9H2F3 | |
| FYHHLPAASGCKQTS | 306 | Q14094 | |
| YGCYVHSSIVPTFHR | 116 | O94983 | |
| IASLNHYLKSHRFPC | 151 | Q8IYT2 | |
| LVHKHFCTRLSGYIE | 241 | Q6PIY7 | |
| AGEKHYHPSCALCVR | 226 | Q6H8Q1 | |
| YCVSGLPEARADHAH | 521 | O95622 | |
| GADFLVHYGHSCLIP | 126 | Q9BZG8 | |
| YVHLGLISTCAFIPH | 381 | Q8TAM1 | |
| LAKRAGAFDAVPCYH | 816 | Q6UB35 | |
| VKRLPLVYCDYHGHS | 1006 | Q9UPW5 | |
| ILHTHLFSCSVDYRP | 1111 | Q2TAZ0 | |
| ETGSHSPVCLQLHYK | 636 | Q96BY7 | |
| LHPKGSLCHYLTQYT | 281 | Q16671 | |
| AHCLPYFRKAQGHEL | 161 | Q8NE62 | |
| SDCYTGPFSRARIHH | 276 | Q9BYT9 | |
| RSRSPHEAGFCVYLK | 421 | Q9NTZ6 | |
| FICTSPLLKYHHCVG | 96 | Q8TCD5 | |
| RHLTLACHYDSKLFP | 161 | Q9NXS2 | |
| HCALRPLDHESYEFK | 366 | Q9UGN5 | |
| HTRFCSHGPKYAELV | 181 | Q9Y5F3 | |
| KAHYRVHTGERPFPC | 161 | Q13886 | |
| TLKGSAHVCLYHPDT | 1876 | Q96PE2 | |
| VHAYFRGHSPSCLAR | 636 | O14526 | |
| EHAPHGHFVTCVKAY | 2401 | Q14517 | |
| HFIKGNDPYCLTISH | 106 | Q8N6C7 | |
| ILYDHVHPVGAFCKT | 261 | Q9H0Q0 | |
| ERHFSISGCPLYHNL | 201 | O95251 | |
| EFAVLPHHSEGACVY | 16 | Q86XX4 | |
| VHLVDSHYCTDPAKF | 141 | Q9H9Y4 | |
| SVVRSYCGHGIHKLF | 286 | P53582 | |
| PHCGNLDYHFVKPFS | 521 | Q9UBI9 | |
| FYPAVEGTLCLTGHH | 21 | Q96QG7 | |
| KVCVEHHTFYRLVSP | 486 | O43491 | |
| PHCLALHSFIDIYTG | 791 | Q12766 | |
| SKGECHRSCPDHYYV | 1596 | Q92824 | |
| FHIPHACLKDNGAYR | 151 | Q96RD9 | |
| FYHEGVPLRHKSVRC | 321 | Q96RD9 | |
| VPHSYCEHIGVARLA | 176 | Q96RD2 | |
| IPHTFCEHIGLAKYA | 176 | Q8NGK2 | |
| DSTHVIRFPLNGYCH | 186 | Q719H9 | |
| IYHLGAASALCRHGK | 16 | P41247 | |
| TEDGCPHKKFFHTRF | 286 | Q5QP82 | |
| EVSFCLPHKIHYAAS | 226 | Q12980 | |
| CKSGYHPTKSHSFRA | 241 | P36980 | |
| TYHVRRHTGEKPYVC | 431 | Q9NPC7 | |
| TGKLHYPRHECISAY | 101 | Q9NZV8 | |
| RILRATGKAYHPHCF | 486 | Q93052 | |
| VRSHDGAVHKPYNCS | 326 | P56270 | |
| DYICHAHFPGTRTII | 206 | P32004 | |
| YHLALLFKDSGHPCT | 331 | Q8TCJ0 | |
| HKFRLHSYSSPTFCD | 101 | P05129 | |
| TLRCGSQKGYHHFVL | 141 | Q6PI73 | |
| TLRCGSQKGYHHFVL | 141 | O75022 | |
| HEGSYLSICKHYRAI | 236 | O00232 | |
| SSHVKHFPICIFGHS | 871 | Q86VP3 | |
| PACVAAHGFRIHDYL | 16 | Q9BSG0 | |
| VISHFYCDVGPSLKA | 171 | Q8NH79 | |
| GHHSKPCSRVEYVSS | 1546 | A7KAX9 | |
| PEHAGTYRCVGIYKH | 86 | Q9H7L2 | |
| RVFHCTQYIRHGSKP | 261 | P00439 | |
| PTVLSRAHLDYCHGD | 156 | Q8N148 | |
| YHGCPFRHSDPELLK | 381 | P49643 | |
| KDLPIHACSYCGIHD | 116 | Q92900 | |
| TRHPISYVCSGAHRK | 1171 | Q5T0Z8 | |
| YGRGTHCHYKAPTVV | 561 | O00144 | |
| LGPYCAETHRRHTLF | 361 | Q9NQ11 | |
| DAIYFHPSTFHCARL | 91 | Q969S8 | |
| LFYEPASGTVLCAHH | 366 | Q5W0U4 | |
| APGERCKSHYAAFSV | 136 | Q9BXJ1 | |
| VHYHPSKVAAAASCL | 301 | O95067 | |
| PVRFAAHHYAATLCA | 291 | Q96CD0 | |
| GPDHCSLLHYAAKTG | 956 | O75912 | |
| HYDINAHACVTGKPI | 246 | P00367 | |
| TLGHYLDKHDPCRCT | 261 | Q8NHY3 | |
| AFKHDPSYTDCHGRQ | 1771 | Q4ZHG4 | |
| KNVCYDHFFPVSHIR | 61 | O95452 | |
| DLAYTPFHAVLKCGH | 206 | Q96SY0 | |
| YIHSFGICHRDIKPQ | 171 | P49841 | |
| ILTAAHCFYGVESPK | 426 | P03951 | |
| PITHHKGCVAATFFV | 511 | Q8IZF7 | |
| FCHSYSICHRDLKPE | 146 | Q8TDC3 | |
| TLCDFPKIHHGFLYD | 21 | Q9BXR6 | |
| YHSHIDAPKDICSGL | 186 | Q6MZM0 | |
| FAGIRSSHIKYICPH | 41 | O75608 | |
| IRSHICSHPGCGKTY | 366 | Q13118 | |
| IFKSHDYRKGHFECP | 126 | Q9UK59 | |
| CHPLKYHTVSYPART | 131 | Q6DWJ6 | |
| RDASFHCAAHYSLPE | 231 | P50895 | |
| ALHCYRKGLTFVSVH | 1136 | O00411 | |
| HSHSLVYVCKPTFVG | 276 | Q9UBP4 | |
| YKHPFTCFAKNTHGI | 306 | P14778 | |
| HKQCTGHIIYPFASD | 71 | Q8NCQ7 | |
| GHIIYPFASDCVRHS | 76 | Q8NCQ7 | |
| HYDINAHACVTGKPI | 246 | P49448 | |
| HIRIHAGYKPFVCEF | 351 | Q8TBJ5 | |
| LPFEKASVCHYHGIE | 646 | Q96DY7 | |
| GCTPLHYAASKNRHE | 106 | O75832 | |
| DKAASECHPHYSFSR | 266 | Q93086 | |
| ECHPHYSFSRLDNKL | 271 | Q93086 | |
| YQHHSTPVCDRKDFV | 396 | Q12947 | |
| HCKFHIYNGTRPCES | 181 | Q93008 | |
| CSDRFKPSYVHSFGL | 231 | Q16518 | |
| HDVAFHPSKCYIASA | 756 | O43815 | |
| PVCPFYSHQLRSKHL | 401 | Q07890 | |
| SRVHVCLYFISPTGH | 156 | Q6ZU15 | |
| VPPDYKIHRHCFTGS | 646 | Q93075 | |
| KIHRHCFTGSYPVIE | 651 | Q93075 | |
| RIHACLYFIAPTGHS | 146 | Q9NVA2 | |
| HCCRGYKHEIPATTL | 616 | Q9NP60 | |
| AFLPSHGLYTCHIGK | 356 | P78414 | |
| RHSDPELYTAAKHCA | 156 | Q9NVX7 | |
| TIGSYFRLNKDTCHP | 561 | A1L4K1 | |
| LPHSSEYSVGRCKHT | 16 | Q9HCL2 | |
| PTSIYHVFHSRKDCA | 426 | Q9HAB3 | |
| LHYIPGHHTCYTASK | 481 | Q6ZSJ9 | |
| AHFRVCEPYTDHKGR | 26 | Q3SXP7 | |
| YHFGFHCPRLSDNKT | 41 | Q3SXP7 | |
| PYCFSIVAGHGKSHV | 386 | Q9NY99 | |
| HCSAEQRHPGKTSVY | 606 | Q9NZP6 | |
| SRIHVCLYFIAPTGH | 146 | Q14141 | |
| RSSCGYTPLHLAAIH | 666 | A6NEL2 | |
| KSDGFPTYHLACVVD | 221 | Q5JPH6 | |
| EELESYKGHFGPIHC | 256 | Q9Y3F4 | |
| GHVRTHTGEKPYACS | 226 | Q3KNW1 | |
| VHSYSHTGERPYKCI | 51 | Q6DJT9 | |
| IGQSSYHHIEPFCKL | 96 | Q7RTV5 | |
| CRHAAIAKYFGDALP | 411 | O94762 | |
| HCYLPSAFSQHKVFV | 1936 | Q63HN8 | |
| KCLHCHGISDTFDPY | 206 | A6NCW0 | |
| ECGKTFTYPSAFHKH | 126 | Q6ZTB9 | |
| CGKAFHSPRSYRRHE | 261 | Q8IYI8 | |
| GFYCPKSFQRHEKTH | 466 | Q8IYI8 | |
| ATCYPDFSKGHLSAI | 601 | Q03169 | |
| TLHQRFHTGEKPYEC | 231 | Q8NDQ6 | |
| IIHYRTHTGEKPYEC | 306 | P17025 | |
| ECGKAFRYPSSLRAH | 356 | Q15935 | |
| CPTYFRRHVKTHSGV | 391 | Q15935 | |
| HFSIHTGEKPYECVE | 466 | Q14592 | |
| HQRIHTGEKPYACSE | 836 | O14709 | |
| VHVRTHTGERPYYCT | 346 | P52747 | |
| VSHQRVHTGEKPYAC | 511 | Q96SZ4 | |
| SLTCHRRCHTGEKPY | 301 | Q96N58 | |
| SAHRRIHTGESPYKC | 621 | Q9NX65 | |
| KCLHCHGISDTFDPY | 206 | A6NCW7 | |
| SCPTYLRSHEKTHTG | 316 | Q9ULM2 | |
| SCEVHERTHFGEKPY | 376 | Q9ULM2 | |
| PFHFVDRLGKHDVTC | 316 | P82933 | |
| GSHEGTVYFKCRHPT | 51 | Q15813 | |
| SVAEGPHHAGCTKSY | 671 | O95428 | |
| PHIYSHGCVLKDVCS | 656 | Q8WWL2 | |
| DHLRVHTSEKPYTCG | 256 | Q9Y2P7 | |
| YVHRRIHTGEKPYTC | 841 | Q8TF20 | |
| TCHEGFKIRYPDLHN | 146 | Q5VX71 | |
| KCLHCHGISDTFDPY | 206 | D6R9N7 | |
| CGKAFRHATSLIYHD | 566 | Q96SK3 | |
| KCLHCHGISDTFDPY | 206 | A8MUK1 | |
| FKHCAEQPSHARTYS | 181 | Q8IV45 | |
| LLHSEVKPYSCHFCG | 371 | Q8N1W2 | |
| KCLHCHGISDTFDPY | 206 | D6R901 | |
| KCLHCHGISDTFDPY | 206 | C9JLJ4 | |
| SSHRKVHTGERPYVC | 441 | Q13398 | |
| HVCLYFITPTGHSLK | 151 | Q92599 | |
| KCLHCHGISDTFDPY | 206 | D6RCP7 | |
| KCLHCHGISDTFDPY | 206 | Q7RTZ2 | |
| HSGTITCLKFYGNRH | 81 | Q9NWT1 | |
| RIHVCLYFISPTGHS | 171 | Q9P0V9 | |
| VVYLGFLCHSRVHPA | 76 | A6NKF7 | |
| PVSPHFVRRQKYCHF | 2191 | Q8IUG5 | |
| FYHAANTRLVPCGHT | 206 | Q96EH8 | |
| HERIHTGEKPYTCPF | 386 | Q8NAM6 | |
| AHQRIHTGEKPYECS | 591 | Q5TYW1 | |
| HQRFHTGKTPFVCSE | 336 | Q9GZX5 | |
| YSHQRAHSGEKPYRC | 416 | Q9UK10 | |
| IRHFSIHTGEKPYEC | 471 | O43296 | |
| KCLHCHGISDTFDPY | 206 | C9JPN9 | |
| HQRIHTGEKPYACSY | 531 | P0CG23 | |
| TRSHTGEKPYECLEH | 236 | P51504 | |
| AFVYPSVCQRHEKSH | 401 | Q8TA94 | |
| HRRTHTGEKPYACTD | 326 | O95201 | |
| AKHQRYHAAVKPFGC | 361 | A6NFI3 | |
| DFEGCHLYRVHGPLK | 221 | Q7Z5H4 | |
| KCLHCHGISDTFDPY | 206 | Q0WX57 | |
| DHPCFLLRGDYSHET | 581 | Q6P2C0 | |
| ECGKVFSYHSALIIH | 376 | B4DU55 | |
| VISIHTKDYPHRCEY | 766 | P17010 | |
| IHQRTHTGEKPYTCS | 446 | O94892 | |
| HFRIHTGEKPYECSE | 446 | P49910 | |
| LRATGKAYHPHCFTC | 456 | Q15942 | |
| STSRHLKGCHPLDYE | 221 | Q9ULT0 | |
| YCGKSFSHPSDLVRH | 431 | Q9UDV6 | |
| ECGKAFSSHAYLIVH | 476 | Q16587 | |
| KCLHCHGISDTFDPY | 206 | P0C7I0 | |
| YLTCHRRLHTGEKPY | 341 | Q7L2R6 | |
| HYRVHTGEKPFSCSL | 391 | Q9Y2Y4 | |
| AYHQRIHTGEKPFEC | 106 | Q14585 | |
| KCLHCHGISDTFDPY | 206 | Q6QN14 | |
| TEHLRTHSGEKPYEC | 491 | Q32M78 | |
| HRISHAGEKPYTCDQ | 141 | O75123 | |
| AGKPEVSSHSCVYIH | 111 | O60806 | |
| KCLHCHGISDTFDPY | 206 | D6RA61 | |
| HCDFKTSDPFILSGH | 651 | Q9Y462 | |
| QVPGTSHFEHLCSYL | 1536 | Q8IWV8 | |
| HKIHTGVRPYECSEC | 306 | Q96HQ0 | |
| HPHELVGKDCRDGFY | 86 | Q04206 | |
| KCLHCHGISDTFDPY | 206 | C9J2P7 | |
| KCLHCHGISDTFDPY | 206 | D6RBQ6 | |
| NASPYHTIVDFHGCL | 226 | P21754 | |
| SAHQRVHTGEKPYTC | 671 | Q14590 | |
| ECGKAFILGSHLTYH | 311 | Q7Z3V5 | |
| YSPHISCHDELLRGT | 236 | Q5VUA4 | |
| NHRGSLHPSSSLYCK | 256 | Q8N228 | |
| GAVYICTEDAFPHKR | 136 | O43542 | |
| VCGKAFSHRGYLIVH | 356 | Q96ND8 | |
| IRHFSIHTGEKPYEC | 471 | Q5CZA5 | |
| PFCGKSFRSAHHLKV | 501 | Q9P2Y4 | |
| CHYCHSLFSGKPEVL | 591 | Q14202 | |
| HYRIHTGEKPYECVG | 236 | Q96CX3 | |
| KCLHCHGISDTFDPY | 206 | Q6R6M4 | |
| YHCPVGEDTLSKIHS | 1111 | A6NCI4 | |
| KCLHCHGISDTFDPY | 206 | D6RJB6 | |
| HRRAHTGEKPYACSD | 246 | A8K8V0 | |
| CLANHTRVHTGEKPY | 551 | Q0VGE8 | |
| AHRRTHTGEKPYTCP | 426 | O60304 | |
| KCLHCHGISDTFDPY | 206 | C9JJH3 | |
| YHGSIHTGERPYECK | 351 | Q96BR6 | |
| SLCNHRSTHTGEKPY | 376 | Q96BR6 | |
| APPCTSEKHYEHLGR | 31 | Q9Y6Q6 | |
| YHQRTHSGEKPFVCR | 421 | Q9Y3M9 | |
| HIRIHTGEKPYACTA | 401 | Q49AA0 | |
| TRHQIFHTGEKPYEC | 391 | Q8N7M2 | |
| KCLHCHGISDTFDPY | 206 | C9JVI0 | |
| AHQRIHTGEKPYECS | 351 | Q4V348 | |
| KGLYATHACGEHLEA | 271 | P07101 | |
| PHSCFRIQHYAGKVL | 506 | O43795 | |
| KDSFSDPYAHICFLH | 1156 | Q9NZM1 | |
| DPYAHICFLHRSKTT | 1161 | Q9NZM1 | |
| TRVCKVSDLHEGHFY | 756 | Q5VTT5 |